mounjaro vs semaglutide for weight loss vs. Ozempic: Drug Comparison Ozempic vs. Wegovy vs. Mounjaro:

4 Wegovy pill offers a magnitude of weight loss that no other oral GLP-1 obesity candidate has been able to duplicate in phase 3 trials, boasting an average weight loss of about 17% (16.6%), when used along with a reduced calorie diet and exercise and if all patients stayed on treatment, compared to about 3% (2.7%) for placebo

"In-house" testing alone is a red flag

The primary stimuli for GLP-1 secretion are meals rich in fats and carbohydrates, and the main action of GLP-1 is to signal nutritional abundance to the brain, reducing our appetite so we dont eat too many doughnuts

The compass that guides decisions too often points to profitnot to the patient

Glucagon failed to increase FOC but exerted a potent positive chronotropic effect in mouse left atrial preparations or mouse right atrial preparations, respectively (Neumann et al